Anna Pawlak – Trademark Portfolio

Entity Type: 01

Anna Pawlak holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VITROFLORA. The owner is based in Lochowo.

Bukowa 3

Lochowo 86-065 , PL

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Anna Pawlak's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

31
Natural Agricultural Products (1 filing)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does Anna Pawlak have?

Anna Pawlak has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Anna Pawlak file in?

Anna Pawlak files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 44 (Medical Services), Class 31 (Natural Agricultural Products). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Anna Pawlak's most well-known trademarks?

Anna Pawlak's registered trademark portfolio includes well-known marks such as VITROFLORA. These are among 1 currently registered trademark in the portfolio.

What is Anna Pawlak's trademark registration success rate?

Anna Pawlak has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.